Low growth and high inflation: a toxic cocktail for anxious markets

Low growth, high inflation, central bank tightening, a strong dollar, and the risk of recession is proving a toxic cocktail for world stockmarkets – and for emerging markets in particular.

View of Rome
Italian bond prices slumped by 25% during six months of unprecedented turbulence
(Image credit: © Alamy)

“Growth is slowing fast, inflation is stubbornly high, and central banks are on the warpath,” say Ajay Rajadhyaksha and Amrut Nashikkar of Barclays. As the world economy enters the second half of the year, “the macro outlook is gloomy”.

Following two years of “chaos” in the pandemic, 2022 was always going to be “a bumpy ride, but nobody expected this – the most turbulent first half global markets have ever seen”, says Marc Jones on Reuters.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Explore More
Markets editor

Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019. 

Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere. 

He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful. 

Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.